1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 8th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Search Results

Search Again
Page 1 of 2
  1. sjJohnny
    Post

    Ampligen - Hemispherx Biopharma re ME/CFS

    And a recent PR related to Ampligen and CFS/ME. AIM ImmunoTech Provides Update on Commercial Launch of Ampligen(R) in Argentina for the Treatment...
    Post by: sjJohnny, Jun 17, 2020 in forum: ME/CFS research news
  2. sjJohnny
    Post

    Ampligen - Hemispherx Biopharma re ME/CFS

    You'll find this interesting - especially for those who were not around for the AdCom meetings of 2012-13. Maybe it can be used to petition the...
    Post by: sjJohnny, Jun 17, 2020 in forum: ME/CFS research news
  3. sjJohnny
    Post

    Ampligen - Hemispherx Biopharma re ME/CFS

    AIM ImmunoTech's Ampligen Receives Clearance from FDA for Exportation to Argentina for the Treatment of Severe Chronic Fatigue Syndrome...
    Post by: sjJohnny, Sep 24, 2019 in forum: ME/CFS research news
  4. sjJohnny
    Post

    Ampligen - Hemispherx Biopharma re ME/CFS

    Hemispherx Links Stanford's ME/CFS Diagnostic to a Potential Path Forward for Ampligen Commercialization ... "This is a potentially landmark...
    Post by: sjJohnny, May 7, 2019 in forum: ME/CFS research news
  5. sjJohnny
    Post

    A nanoelectronics-blood-based diagnostic biomarker for ME/CFS (2019) Esfandyarpour, Davis et al

    LOTS of coverage. I hope it pans out....
    Post by: sjJohnny, Apr 30, 2019 in forum: ME/CFS research
  6. sjJohnny
    Post

    Ampligen - Hemispherx Biopharma re ME/CFS

    They have 2 cancer trials underway, IRB approval to start the triple negative breast cancer and a planned start to ovarian trial at the end of...
    Post by: sjJohnny, Jan 13, 2019 in forum: ME/CFS research news
  7. sjJohnny
    Post

    Ampligen - Hemispherx Biopharma re ME/CFS

    Not to get technical Danny, but the Advisory Committee gave a mostly negative vote in December of 2012, with the FDA declining approval in...
    Post by: sjJohnny, Jan 12, 2019 in forum: ME/CFS research news
  8. sjJohnny
    Post

    Ampligen - Hemispherx Biopharma re ME/CFS

    No details are known, I think they are still negotiating (and have been for a long while). My guess would be 300+
    Post by: sjJohnny, Jan 2, 2019 in forum: ME/CFS research news
  9. sjJohnny
    Post

    Ampligen - Hemispherx Biopharma re ME/CFS

    I've heard that Peterson is limiting his ampligen patients. The paragraph refers to a future planned trial (to satisfy the FDA, the 2nd...
    Post by: sjJohnny, Jan 2, 2019 in forum: ME/CFS research news
  10. sjJohnny
    Post

    Ampligen - Hemispherx Biopharma re ME/CFS

    Indeed. That's always been the problem with the amp-511. Few can afford it.
    Post by: sjJohnny, Dec 20, 2018 in forum: ME/CFS research news
  11. sjJohnny
    Post

    Ampligen - Hemispherx Biopharma re ME/CFS

    Hemispherx Biopharma Inc. Announces First Large Ampligen Shipment to a Clinical Site for Use in U.S. Expanded Access Program...
    Post by: sjJohnny, Dec 19, 2018 in forum: ME/CFS research news
  12. sjJohnny
    Post

    Ampligen - Hemispherx Biopharma re ME/CFS

    Contact hemispherx to find out the status.... GP-Pharm is handling Argentina. http://gp-pharm.com/
    Post by: sjJohnny, Dec 19, 2018 in forum: ME/CFS research news
  13. sjJohnny
    Post

    Ampligen - Hemispherx Biopharma re ME/CFS

    That AMP-511 is a compassionate treatment protocol that’s been available for 20 years. FDA wants one more large trial. Argentina has approved.
    Post by: sjJohnny, Dec 18, 2018 in forum: ME/CFS research news
  14. sjJohnny
    Post

    Ampligen - Hemispherx Biopharma re ME/CFS

    Yes, by IV. It’s a large molecule drug, so it’s doubtful that will ever change.
    Post by: sjJohnny, Dec 18, 2018 in forum: ME/CFS research news
  15. sjJohnny
    Post

    Ampligen - Hemispherx Biopharma re ME/CFS

    From today's PR: In parallel, we continue to pursue Ampligen for the treatment of severe myalgic encephalomyelitis/chronic fatigue syndrome...
    Post by: sjJohnny, Oct 22, 2018 in forum: ME/CFS research news
  16. sjJohnny
    Post

    Ampligen - Hemispherx Biopharma re ME/CFS

    Hemispherx Opens FDA-Approved Reimbursement Based Expanded Access Treatment Program for ME/CFS to New Enrollees at Approved Clinical Sites in...
    Post by: sjJohnny, Jun 27, 2018 in forum: ME/CFS research news
  17. sjJohnny
    Post

    Ampligen - Hemispherx Biopharma re ME/CFS

    cGMP = Current Good Manufacturing Practices
    Post by: sjJohnny, Jun 20, 2018 in forum: ME/CFS research news
  18. sjJohnny
    Post

    Ampligen - Hemispherx Biopharma re ME/CFS

    Hemispherx Comments on $500+ Million Market Opportunity for Ampligen®, the Only Late Stage ME/CFS Candidate in the U.S. . . . Dr. Daniel Peterson,...
    Post by: sjJohnny, Jan 23, 2018 in forum: ME/CFS research news
  19. sjJohnny
    Post

    Ampligen - Hemispherx Biopharma re ME/CFS

    Here is a workshop announcement Link: http://solvecfs.org/fda-drug-development-workshop-dates-announced/ (The Federal Register link no longer...
    Post by: sjJohnny, Jan 22, 2018 in forum: ME/CFS research news
  20. sjJohnny
    Post

    Ampligen - Hemispherx Biopharma re ME/CFS

    Excellent letter by Hemispherx CEO. Filed with the SEC https://www.sec.gov/Archives/edgar/data/946644/000149315218000820/ex99-1.htm January 22,...
    Post by: sjJohnny, Jan 22, 2018 in forum: ME/CFS research news
Showing results 1 to 20 of 26 Next >
Search Again
Page 1 of 2